open access

Vol 72, No 3 (2021)
Clinical vignette
Submitted: 2021-02-06
Accepted: 2021-02-23
Early publication date: 2021-03-22
Get Citation

Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course

Ognian Kalev1, Marina Hodolic23, Berndt Tomancok4, Michael Sonnberger5, Markus Hutterer6, Daniela Ehrlich7, Robert Pichler8
DOI: 10.5603/EP.a2021.0027
·
Pubmed: 33749817
·
Endokrynol Pol 2021;72(3):282-283.
Affiliations
  1. Institute of Pathology and Neuropathology, Neuromed Campus, Kepler University Hospital, Linz, Austria
  2. Nuclear Medicine Research Department, IASON, Graz, Austria
  3. Nuclear Medicine Department, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
  4. Department of Neurosurgery, Neuromed Campus, Kepler University Hospital, Linz, Austria
  5. Institute of Neuroradiology, Neuromed Campus, Kepler University Hospital, Linz, Austria
  6. Department of Neurology, Neuromed Campus, Kepler University Hospital, Linz, Austria
  7. Department of Gerontology, Neuromed Campus, Kepler University Hospital, Linz, Austria
  8. Institute of Nuclear Medicine, Neuromed Campus, Kepler University Hospital, Linz, Austria

open access

Vol 72, No 3 (2021)
Clinical Vignette
Submitted: 2021-02-06
Accepted: 2021-02-23
Early publication date: 2021-03-22

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

acromegaly; Cushing´s disease; somatostatin receptor subtype; immunohistochemistry; somatostatin analogues

About this article
Title

Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course

Journal

Endokrynologia Polska

Issue

Vol 72, No 3 (2021)

Article type

Clinical vignette

Pages

282-283

Early publication date

2021-03-22

Page views

656

Article views/downloads

208

DOI

10.5603/EP.a2021.0027

Pubmed

33749817

Bibliographic record

Endokrynol Pol 2021;72(3):282-283.

Keywords

acromegaly
Cushing´s disease
somatostatin receptor subtype
immunohistochemistry
somatostatin analogues

Authors

Ognian Kalev
Marina Hodolic
Berndt Tomancok
Michael Sonnberger
Markus Hutterer
Daniela Ehrlich
Robert Pichler

References (6)
  1. Dai C, Liu X, Ma W, et al. The Treatment of Refractory Pituitary Adenomas. Front Endocrinol (Lausanne). 2019; 10: 334.
  2. de Bruin C, Feelders RA, Lamberts SWJ, et al. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev Endocr Metab Disord. 2009; 10(2): 91–102.
  3. de Herder WW, Reijs AEM, Feelders RA, et al. Diagnostic imaging of dopamine receptors in pituitary adenomas. Eur J Endocrinol. 2007; 156 Suppl 1: S53–S56.
  4. Liu H, Zakiniaeiz Y, Cosgrove KP, et al. Toward whole-brain dopamine movies: a critical review of PET imaging of dopamine transmission in the striatum and cortex. Brain Imaging Behav. 2019; 13(2): 314–322.
  5. de Bruin C, Pereira AM, Feelders RA, et al. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab. 2009; 94(4): 1118–1124.
  6. Gabalec F, Beranek M, Netuka D, et al. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas. Pituitary. 2012; 15(2): 222–226.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl